Related Experiment Video
Updated: Jun 20, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Chronic interstitial lung diseases in children.
Maria Aparecida Soares de Souza Paiva1, Sandra Mara Moreira Amaral
1Hospital dos Servidores do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil. mariaaparecida.paiva@gmail.com
Summary
Pediatric interstitial lung diseases (ILDs) differ from adult forms, presenting unique clinical spectra and requiring tailored classifications. Multicenter studies aim to standardize diagnosis and treatment for these rare childhood lung conditions.
Area of Science:
- Pediatric Pulmonology
- Rare Diseases
- Interstitial Lung Diseases
Background:
- Interstitial lung diseases (ILDs) in children are rare, heterogeneous disorders often classified based on adult data.
- Pediatric ILDs exhibit a broader clinical spectrum, distinct courses, and varied treatment responses compared to adults.
- Infantile lung development influences new clinical forms, necessitating specialized classification for pediatric ILDs.
Purpose of the Study:
- To review the conceptualization and classification of pediatric ILDs, considering their unique characteristics.
- To highlight differences in clinical presentation and newly described entities in young children.
- To emphasize the need for standardized diagnostic and therapeutic strategies in pediatric ILDs.
Main Methods:
- Review of existing literature on pediatric ILDs.
- Historical analysis of multicenter studies focused on childhood ILDs.
- Comparison of adult and pediatric ILD classifications and clinical presentations.
Main Results:
- Pediatric ILDs present unique clinical features and disease courses not fully captured by adult classifications.
- New clinical entities and variations are increasingly described in infants, broadening the classification scope.
- Genetic surfactant dysfunction is a key differential diagnosis in pediatric ILDs.
Conclusions:
- Standard adult criteria for ILDs do not entirely apply to children, necessitating specialized approaches.
- Multicenter studies are crucial for advancing knowledge and standardizing management of pediatric ILDs.
- Standardized laboratory, radiological, and biopsy protocols are essential for accurate diagnosis and treatment.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...